NCT05819762Completed
Evaluation of ClearLLab LS Screening Panel
Evaluation of ClearLLab LS Screening Panel for the Diagnosis of Hematological Malignancies
Source: ClinicalTrials.gov · Last updated 4 Dec 2024
Brief summary (registry, in English)
This is a multi-center study to evaluate the clinical performance of ClearLLab LS screening panel with specimens from subjects for the diagnosis of hematologic malignancies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 831 (actual)
- First submitted
- 22 Mar 2023
- Start date
- 25 May 2023
- Primary completion date
- 15 Oct 2024
- Lead sponsor
- Beckman Coulter, Inc.
- Diseases
- Childhood cancers
- NCT number
- NCT05819762
What you commit to
- Study type: Observational
- Participants enrolled: 831
- From 25 May 2023 to the primary completion date, 15 Oct 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Samples from subjects with known myeloid malignancies or multiple myeloma
Age
- Specimens and/or spent samples collected in Ethylene Diamine Tetraacetic Acid (EDTA) anticoagulant older than 24 hours from time of collection
- Specimens and/or spent samples collected in Heparin or Acid Citrate-Dextrose (ACD) anticoagulant older than 48 hours from time of collection
Other
- Specimens and/or spent samples that are visibly hemolyzed
- Specimens and/or spent samples that are visibly clotted
- Samples with insufficient volume to complete the protocol tests
Who the study is looking for
- Residual whole blood, bone marrow, or lymph node tissue samples from subjects with hematologic tumor-related symptoms and/or signs that are clinically recommended for Flow Cytometry Immunophenotyping
Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Nanjing Medical University Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
| The First Affiliated Hospital of Soochow University Coordinator of this site? Confirm its status | Suzhou | China | Unknown status |
| Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
| Tongji Hospital Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.